Protein Polymer Technologies to Present At BiomaterialsOf The Future Conference
SAN DIEGO, Nov. 13, 1997 -- Protein Polymer Technologies,
Inc. (Nasdaq: PPTI), will present at the Medical Data International's "Biomaterials
of the Future" Conference on Tuesday, November 18, 1997 at the ANA
Hotel in San Francisco. This two-day conference brings together experts
and emerging medical companies to discuss latest advances in the development
of new biomaterial technologies in the cardiovascular, musculoskeletal and
surgical marketplace.
Joseph Cappello, Ph.D., Vice President of Research &
Development and Chief Technical Officer will discuss latest achievements
with PPTI's development programs, including new ProLastin(TM) hydrogels
targeted for the treatment of incontinence. Other targeted applications
include tissue adhesives and sealants, wound healing, contact lens coatings,
surgical adhesion barriers and drug delivery vehicles.
Protein Polymer Technologies, Inc., a San Diego-based
biotechnology company, has a technology platform that allows the creation
of a number of different classes of biocompatible polymers that enable cell
growth, promote the regeneration of tissue, bond to synthetic surfaces and
resorb into tissue at controlled rates. PPTI's lead program, a new
generation of surgical adhesives and sealants to replace or augment the
use of sutures and staples, is being developed in collaboration with Ethicon,
a Johnson & Johnson company.
CONTACT:
Lisa Swann, Director, Investor Relations
619-558-6064
info@ppti.com
